| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 06/14/2016 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/14/2016 | 5:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/14/2016 | 5:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/07/2016 | 6:11AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/03/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals to Present at 6th Annual LD Micro Invitational on June 8, 2016 | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/01/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/12/2016 | 4:09PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/12/2016 | 4:05PM | PR Newswire (US) | Imprimis Pharmaceuticals Announces First Quarter 2016 Financial Results and Provides Business Update | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/12/2016 | 4:03PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/12/2016 | 8:30AM | PR Newswire (US) | Clinical Study of Imprimis Pharmaceuticals' Tri-Moxi-Vanc Dropless Therapy Formulation Show Statistically Significant Reducti... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/05/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Announces Plans to Launch IV Free™ Conscious Sedation and New Compounded Triple Drop Formulations ... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/04/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals to Host its First Quarter 2016 Financial Report Conference Call and Webcast on May 12, 2016 at 4:30 ... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/02/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Begins Dispensing Lower Cost Alternative to Thiola® | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/27/2016 | 4:02PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/27/2016 | 4:01PM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/26/2016 | 7:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/26/2016 | 7:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/26/2016 | 5:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/12/2016 | 7:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Registers its Texas Facility with the FDA as an Outsourcing Facility | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/05/2016 | 6:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/05/2016 | 6:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 04/05/2016 | 6:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/28/2016 | 2:26PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/23/2016 | 4:07PM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/23/2016 | 4:07PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/23/2016 | 4:05PM | PR Newswire (US) | Imprimis Pharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results and Provides Business Update | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/21/2016 | 4:18PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/17/2016 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2015 Financial Report Conference Call and Webcast on Marc... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 03/16/2016 | 4:05PM | PR Newswire (US) | Imprimis Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |